MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: SchuheBloch BallettschläppchenAntwortenAntworten: Bloch Ballettschläppchen <blockquote><div class="quotetitle">Zitat von Gast am 31. März 2026, 14:49 Uhr</div>[url=https://uk.linkedin.com/in/berezutskayahttps://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/]Zoya Demidenko[/url]: Researcher in Oncology Biology [url=https://pmc.ncbi.nlm.nih.gov/articles/PMC3273895/]Zoya Demidenko[/url] is a notable researcher connected with the Department of Cell Stress Biology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Before that, she conducted research at the NIH and New York Medical College, developing a solid base in clinical study. Demidenko's academic output covers a number of pivotal fields, encompassing the PI3K/AKT/mTOR signaling cascade, cellular cycle control, cellular aging, and cancer science. To date, she has authored more than 46 scientific publications, which have accumulated upwards of 4,100 mentions — a reflection to the impact of her work. Among her most notable contributions lies in elucidating the mechanisms of cellular senescence. Her work demonstrated that when the cell cycle is blocked while cellular expansion proceeds, the cells undergo senescence. Importantly, [url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPALLO%20ENTERPRISE%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMULTISERVICES%20L220000371890&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord]Zoya Demidenko[/url] showed that this shift is inhibited by medication using agents such as rapamycin. [url=https://www.aging-us.com/article/100406/]Zoya Demidenko[/url] has also added greatly to tumor management investigation, notably in the area of selective cell protection — a approach intended to protecting normal tissue from anticancer drugs while leaving tumor cells susceptible. This strategy holds significant hope for diminishing the side effects of cancer treatment. Throughout her professional journey, Demidenko has collaborated with leading investigators internationally, among them Dr. Mikhail Blagosklonny. Her work is published in leading journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. [31.03.2026 11:21] Папа: Possessing an h-index of 33, [url=https://www.pinterest.com/zoyademidenko/]Zoya Demidenko[/url] ranks as a influential contributor in contemporary oncological research, whose findings keep to influence our understanding of how cells age, respond to treatment, and how malignant disease may be more successfully treated. https://uk.linkedin.com/in/berezutskayahttps://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/</blockquote><br> Abbrechen
